© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Dibutyryl cyclic adenosine monophosphate sodium, known as dibutyryl cAMP sodium or dbcAMP-Na, arrived on the scientific stage early in the push to understand intracellular signaling and regulation. Researchers in the 1960s struggled to decode how cells communicate and respond to external stimulation. Pure cyclic AMP couldn’t cross cell membranes easily, limiting experiments. Modified forms like dbcAMP—created by attaching butyryl groups—changed that landscape by sneaking through cell walls, sparking new lines of inquiry in cell biology, neurobiology, and pharmacology. Back then, these discoveries powered breakthroughs in understanding smooth muscle contraction, hormone signaling, and synaptic plasticity. Early lab reports told the story of workbench persistence and the gradual piecing together of molecular puzzles. Long hours distilled into foundational knowledge laid the groundwork for modern signal transduction research.
Today’s dbcAMP sodium comes as a nearly white powder, moisture-sensitive and designed for quick solubility in aqueous systems. Researchers pick it up to mimic endogenous cAMP activity, betting on its reliability in boosting intracellular cAMP levels across cell models. Life science companies offer high-purity grades—greater than 98% pure by HPLC—catering to researchers who need clean, traceable materials. Package sizes range from small milligram vials for research to industrial lots for larger production. Alongside sodium salt, there are other forms, but the sodium salt remains a staple for water-based work.
With a chemical formula of C20H33N5NaO11P and a molecular weight around 577.5 g/mol, dbcAMP sodium dissolves readily in water or mild buffers. The sodium salt form confers both stability and compatibility with cellular assays. Its slightly hygroscopic character demands storage in tightly sealed containers, at 2–8°C, with desiccants. The powder appears almost white and odorless, and dissolves clear when properly prepared. In practical practice, researchers notice its characteristic ability to dissolve above 100 mM in water, making it a dependable option for in vitro studies where concentration and osmolarity can tip the balance between signal and noise.
Manufacturers label dbcAMP sodium with product code, lot number, manufacturing date, and shelf life. Regulatory standards require indication of purity (frequently 98% or higher), residual solvent analysis, heavy metal screening, and endotoxin levels. Material safety data sheets (MSDS) accompany each batch, listing recommended handling precautions and emergency measures. Researchers appreciate clear labeling of reconstitution instructions, shelf life at recommended temperatures, and details about pH and ionic strength at given concentrations. Traceability, from raw material origin to batch documentation, sticks as a non-negotiable point under current Good Manufacturing Practice (cGMP) and ISO standards.
Typical synthesis routes start from adenosine monophosphate (AMP) and incorporate butyryl chloride via an acylation step under controlled pH and temperature. Experienced chemists neutralize the solution with sodium carbonate, then perform chromatography to separate the desired diester cyclic nucleotide. Careful crystallization and drying minimize solvent residue and impurities. Every step needs tight control—yield and purity hinge on reaction completeness and purification method. In larger-scale preparation, in-process controls monitor reagent addition, temperature fluctuations, and mixing rates to avoid runaway reactions or incomplete conversions.
Applying dbcAMP sodium in the lab often means exploiting its hydrolysis, where intracellular enzymes quickly strip the butyryl groups, releasing active cAMP. Scientists sometimes tweak its structure, swapping out butyryl arms for other acyl groups to modulate membrane permeability or stability. Derivatives formed through esterification, or slightly altered ring structures, serve as molecular tools for selective signaling or as photolabile versions for time-resolved experiments. Enzymatic and acid-catalyzed hydrolysis, or targeted chemical modifications, let experts fine-tune the molecule’s properties for novel research questions.
Dibutyryl cAMP sodium appears in catalogues and articles as sodium dibutyryl cyclic 3′,5′-adenosine monophosphate, dbcAMP sodium, or sodium salt of N6,2′-O-dibutyryl cyclic AMP. Brand names differ among suppliers like Sigma-Aldrich, MedChemExpress, and Carbosynth, but the core product offers the same molecular identity. Confusion sometimes comes from similar abbreviations for related cyclic nucleotides, so experts pay close attention to full chemical names and CAS numbers during orders to keep projects on track.
Manufacturing dbcAMP sodium follows Good Laboratory Practices (GLP), with stringent quality checks on impurity profiles and batch records. Handling in the lab doesn’t pose acute risk but still requires eye protection, gloves, and avoidance of inhalation or skin contact. Waste disposal rules—dictated by local biosafety and chemical safety guidelines—classify excess or expired stock for incineration or hazardous waste disposal rather than routine lab trash. Spills must be wiped with damp towels and disposed of safely. Product specification sheets and MSDS communicate risk, safe storage, and troubleshooting tips, building a culture of accountability and low-risk operation in everyday research.
Researchers regularly reach for dbcAMP sodium in cell signaling experiments, stem cell differentiation studies, and pharmacological research. Its role as a cell-permeable cAMP analog makes it valuable for studies on kinase activation, transcription regulation, and memory formation in neurons. Stem cell biologists add it to media when nudging primitive cells toward cardiac, neural, or pancreatic fates. In muscle research, dbcAMP sodium plays a role in dissecting how cAMP alters contraction or growth signals. Immunologists, too, employ it to trace cAMP’s influence on cytokine production and lymphocyte function. Its reach extends into veterinary and plant science spheres, as related signaling pathways crop up throughout biology.
Over decades, research with dbcAMP sodium crystallized important knowledge about cyclic nucleotide function. Labs now leverage its stability to test hundreds of experimental conditions quickly. Recent years brought new interest as drug discovery turned to cyclic nucleotide signaling in cardiovascular disease, neurodegeneration, and metabolic disorders. Companies developing cell therapies use dbcAMP sodium in culture formulations designed to push cells toward defined phenotypes, especially when replacing or healing damaged tissues. Academic projects often start with off-the-shelf dbcAMP sodium, and then graduate to designer versions—engineered to act faster or longer, or to target specific proteins inside the cell.
Direct toxicity from dbcAMP sodium rarely causes headaches in cell culture models, but long-term exposure or dosing beyond an established window dampens cell viability and changes transcriptional profiles. Studies conducted in rodents show tissue distribution depends on administration route and dosing, with rapid breakdown and clearance in vivo. Cellular toxicity links most often to excessive activation of cAMP-dependent protein kinases and downstream gene expression, which can disrupt normal physiology. Regulatory limits for research and pharmaceutical development reflect these risks, demanding dose-finding and in vivo safety experiments before any move to clinical work.
What’s ahead for dbcAMP sodium? Gene and cell therapies depend on efficient ways to manipulate intracellular signals, so the demand for custom cAMP analogs is rising. Advances in drug delivery—like nanoparticles—hint at broader therapeutic uses, nudging research labs and producers to investigate stability, bioavailability, and targeting strategies. Upcoming generations of analogs are being designed to evade rapid breakdown, reduce off-target effects, and direct their activity more precisely in specific tissues. Research collaborations between chemical manufacturers, academic labs, and clinical outfits underscore how cyclic nucleotides might help turn next-generation therapies from idea to reality. Patents pile up for novel analogs, coupled with new analytical tools for high-throughput screening of cAMP target proteins. The race to unlock new uses of dbcAMP sodium and its kin isn’t slowing. Instead, more researchers and companies are betting that this small molecule—born from simple chemical tweaks—will keep playing a big role in the decades to come.
Dibutyryl cyclic adenosine monophosphate sodium, usually shortened to dibutyryl cAMP, shows up in many research labs because scientists use it to mimic signals inside cells, especially for work with cell growth, differentiation, and communication. This molecule offers something special. It acts like a messenger, helping researchers simulate how cells respond to signals from the environment. I remember working through cell biology labs, surrounded by flasks and pipettes, waiting to see if the cells would change color or spread out differently. We relied on dibutyryl cAMP to dig deeper into why some cells mature into muscle while others develop as fat or nerve tissue.
Doctors and scientists have paid close attention to how dibutyryl cAMP triggers insulin release from pancreatic cells. Diabetes affects hundreds of millions worldwide. Solutions don’t appear overnight, but finding ways to push pancreatic cells to release insulin has inspired decades of research. Dibutyryl cAMP lets scientists test and discover which combinations of signals make these cells work harder—and more efficiently. This drives innovation for better treatments, backed by teams racing to help patients manage blood sugar without constant ups and downs.
Neuroscience teams often reach for dibutyryl cAMP when growing nerve cells in a dish. In the quest to repair nerves after injury or help those with spinal cord damage, researchers need cells that can survive, extend, connect, and actually function. Studies use this compound to guide the growth and branching of nerve fibers. Picture a lab full of microscopy images—some cells fail to reach out, others send long, healthy connections. Dibutyryl cAMP gives those nerve cells a fighting chance, which opens the door to understanding recovery after injury or even treating conditions like multiple sclerosis.
Not all cAMP compounds work the same in tests. Some fail to pass through cell membranes. Dibutyryl cAMP stands out because it crosses into cells more easily due to its structure. This matters for research on muscle and fat cell development, where tweaking the chemical signals in a petri dish can mean the difference between cells that stay the same and those that begin to specialize. Scientists use this data when testing ideas for weight loss medication or therapies for muscle wasting, drawing a line straight from petri dish to clinic.
No chemical comes with a free pass. Dibutyryl cAMP’s ability to enter cells quickly raises questions about safety, especially outside a controlled lab setting. Using this compound carelessly, even with the promise of breakthroughs, puts both research models and people at risk. It reminds me of stories from mentors who stressed smart lab practice: learning the risks, following protocols, and double-checking every step. Scientists remain focused on using dibutyryl cAMP where it offers a clear advantage, not where shortcuts could lead to harm.
At the end of the day, dibutyryl cAMP isn’t just for scientists looking for a quick result. It helps unlock new treatments for real people, from diabetes to nerve damage. Using this compound wisely, based on strong evidence and ethical standards, turns a complex molecule into hope for those in desperate need. Good science comes from curiosity, discipline, and respect for both progress and safety—qualities this research chemical continues to demand from everyone who reaches for the bottle.
Dibutyryl Cyclic Adenosine Monophosphate Sodium sounds like a mouthful, but in research labs, it shows up on plenty of shelves. Dealing with chemicals like this one means taking storage seriously. At one point, I worked in a university lab where materials piled up in freezers and cabinets, some labeled, some forgotten. Mess like that can put people and work at risk. Thinking carefully about where you put each chemical makes a difference. Skipping those steps may cost you ruined research, or worse, can hurt the people around you.
Water sneaks into everything, especially powders. Dibutyryl Cyclic Adenosine Monophosphate Sodium draws moisture from the air and turns to goop if left open, making it useless. Dry storage keeps it steady. Most labs use desiccators or sealed containers with drying agents. At home, it’s like keeping crackers crispy in a tin instead of leaving them out for the humidity to get at. A tight cap and watching the container for cracks matter just as much here.
Heat speeds up breakdown in chemicals. With this compound, cool storage protects its structure. Researchers put vials in the refrigerator or even colder spaces, sometimes hitting -20°C. In my experience, refrigerators fill up fast, overloaded with things supposed to keep cool; veggies pushed to the back, boxes of weird chemicals stacked high in every available spot. That’s chaos, not safety. Each item, especially this compound, deserves its own place, away from fridge doors or heat sources.
Light can trigger changes in many compounds. Some chemicals fall apart, others become dangerous. I remember working night shifts, flipping bottles to read hand-written notes, only to see some samples clump together or fade in color after too many days near the light. Wrapping vials in foil or picking an amber glass container can save you lots of trouble in the long run. Those extra steps stop waste before it starts.
In labs, labels get ignored all the time. That mess guarantees disaster. A clear date, name, and short storage instruction stops people from grabbing the wrong vial or tossing out the good stuff by mistake. If each person assumes “I’ll remember what this white powder is,” someone else always pays for it. I've learned that a cheap piece of tape and a marker go a long way for everyone’s sanity.
Safe storage isn’t just a list of rules. It keeps communities safe, research strong, and cuts down mistakes. The Centers for Disease Control and peer-reviewed journals like the Journal of Biological Chemistry highlight that ruined samples waste time and funding, not just for the project, but for the entire group depending on results. For long-term storage, splitting your supply into smaller portions helps keep each batch fresh. Old habits die hard, but if enough people in a workspace handle chemicals with care, you see fewer messes and more trust.
Digital lab management and regular clean-up days help keep storage habits sharp. Training matters, not just for those handling Dibutyryl Cyclic Adenosine Monophosphate Sodium, but for anyone who might walk past its shelf. These tools shouldn’t be optional. Anyone working with this or similar compounds will tell you: a safe, dry, and organized chemical shelf makes for smoother days and better discoveries.
Dibutyryl cyclic adenosine monophosphate (often called dbcAMP or dibutyryl cAMP sodium) belongs to a class of chemicals known for modulating cell signaling. Researchers got interested in it because it mimics a naturally occurring messenger, cAMP, involved in an impressive variety of cellular processes—think metabolism, hormone signaling, even memory formation at the neuronal level. The sodium salt makes it easy to dissolve in water, opening the door for easy handling in lab setups.
The questions about recommended dosages come up mainly among scientists and a few clinicians experimenting with cell cultures, animal models, or sometimes even rare human protocols. You won’t find an FDA-approved, off-the-shelf use for dbcAMP sodium in mainstream medicine. No big surprise there—regulatory agencies haven’t cleared this compound for routine clinical use. Most dosage conversations lean on what researchers have published, not what’s recognized as standard of care.
Most of the peer-reviewed literature uses doses that span a wide range, largely depending on the goal and the system in play. In cell culture, for example, common concentrations float between 0.1 millimolar and 1 millimolar. Some protocols go higher, up to 5 millimolar, to boost signaling for short periods. For animal research, things get trickier—rat studies often use anywhere from 10 to 200 mg per kilogram of body weight, either as a single injection or divided across a few administrations.
One paper I came across, studying neuroprotective effects in rats, landed on 50 mg/kg given intraperitoneally. Meanwhile, cell culture experiments probing differentiation in stem cells often pick 0.5 millimolar as a sweet spot that balances effectiveness with low toxicity. Researchers usually choose these doses based on trial and error, pilot studies, and sometimes by matching previous work, not from a set formula. Human data are almost nonexistent. Attempts to extrapolate from animal or cell culture studies don’t translate smoothly because metabolism, distribution, and clearance jump around so much between species.
Dosage questions shouldn’t stay hypothetical. Getting it wrong in the lab often means wasted time, unclear data, or safety issues. In my own experience, skimping on carefully reading protocols or miscalculating concentrations led to ruined cell cultures. Each small mistake means researchers lose weeks of work. For folks outside the lab, chasing after purity or experimenting without clear professional guidance pushes into a dangerous grey area. The compound acts as a potent signaling modulator. Overdosing could produce unpredictable cellular or system-wide changes, especially since cAMP pathways lie at the core of heart rhythm regulation, glucose metabolism, and even immune responses.
To cut the confusion, everyone working with compounds like dbcAMP sodium ought to check published studies in peer-reviewed journals first. Journals like the Journal of Biological Chemistry or Nature Protocols list the dosages, time courses, and observed effects in plain detail. Beyond this, connecting with colleagues or consulting with experienced pharmacologists goes a long way toward avoiding costly or dangerous mistakes.
Some advocate for an online, regularly updated database where scientists can share protocols and outcomes on compounds like dbcAMP sodium—sort of a living resource for best practices, not buried in supplementary materials. Moving from isolated trial-and-error to transparent, collaborative standards gives everyone better information, fewer wasted resources, and safer labs. Before picking up a new reagent, weighing the risks, checking established methods, and starting at the lower end for dose-finding remains the most honest way to protect both data integrity and health.
Dibutyryl cyclic adenosine monophosphate sodium (often called dibutyryl cAMP) has stirred up quite a few conversations across research labs. Scientists lean on it to mimic or trigger responses linked to real cAMP in the body. The goal: unlock clues on how cells talk, respond to hormones, and kick off growth or healing. Many cell studies give dibutyryl cAMP a starring role, especially in Monday-to-Friday medical research settings. Some folks wonder whether new uses outside the lab, like supplements or experimental therapies, could cause side effects.
Every drug tweaks the body’s balance, and dibutyryl cAMP is no exception. Medical journals report that in some animal studies, this molecule altered heart rates and blood pressure. Researchers spotted increased urine output, and even muscle twitching or agitation at higher doses. Scientists in cell culture labs also mention that too much can kill off sensitive cells. Experiments with mice have shown that large doses push the heart and kidneys outside their comfort zones.
Human studies don’t pile up the same mountains of data. That’s mostly because, outside research, doctors don’t write dibutyryl cAMP prescriptions. The body breaks it down into butyrate and adenosine, both of which bring their own effects. Extra adenosine in the body, for example, slows heart conduction and can sometimes mean trouble for folks with heart rhythm concerns. Butyrate, on the other hand, usually gets handled well, though in big enough amounts, even that can affect gut comfort.
Some scientists worry that tinkering too much with natural cAMP cycles inside cells could have ripple effects. The human body keeps precise checks and balances for these chemicals for a reason. Knocking them out of whack for too long, especially in developing tissues or in organs like the heart or brain, could spell trouble down the line. Animal models have raised eyebrow about reproductive impacts, and muscle development sometimes stalls under heavy doses.
Most of the hard evidence comes from journal papers and rapid-fire research updates. A study in the Journal of Pharmacology (2018) linked high levels with changes in renal function and shifts in electrolyte balance. A paper in Cellular Signalling saw sharp stress responses in heart muscle with repeated injections. Still, no big human clinical trials have delivered clear safety rules, so guidance often falls back on animal and cell tests.
Curiosity about experimental compounds slides quickly toward the mainstream. Some wellness corners or alternative medicine groups already hint at using dibutyryl cAMP for boosting athletic performance, improving mood, or aiding recovery. Most of the time, clear warnings and directions remain buried behind marketing. Everyday folks deserve full knowledge of the unknowns before they jump in. Internet suppliers sometimes pitch this stuff without outlining the fine print that researchers already worry about — or without keeping doses in safe ranges.
The first step comes down to education. Scientists, doctors, and medical writers ought to speak up about the messy middle ground: not everything that looks promising in a test tube should roam free in health stores. Regulators could tighten rules for online vendors who sell research chemicals. Anyone eyeing experimental therapies should have real conversations with a professional and weigh potential risks. Open science makes sure both the positives and the negatives get a fair hearing. Real safety means pooling knowledge, not crossing fingers and hoping for the best.
Anyone who has spent time in a cell culture lab knows the difference between research-only chemicals and those cleared for deeper, more regulated applications. Dibutyryl cyclic adenosine monophosphate sodium, or db-cAMP, offers scientists a stable and cell-permeable cAMP analog. This property attracts interest from many labs wanting to mimic cAMP’s effect or boost protein kinase A activity. If the product label carries “research use only,” it deserves close reading rather than a quick glance. These three words signal a boundary: the product supports controlled lab settings but stays out of clinical or therapeutic use.
People sometimes overlook small details in pursuit of results. It’s easy to think purity levels, trace contaminants, and manufacturing practices take a backseat to price or convenience. That choice can put research outcomes or even personal health at risk. Research-use only labels often cover products produced under standards designed to keep prices reasonable and focus quality control on what matters most for basic research: reproducibility and consistency in a Petri dish. A certified-grade chemical for clinical use carries much stricter requirements, from sterile handling environments to validation for every lot. The FDA, EMA, and other regulatory bodies track the path of each batch of these higher-standard substances, but research-grade chemicals dodge those costs and controls. These differences in oversight ensure researchers do not mix up bottles with different intended uses.
In my own early days working with primary neuron cultures, db-cAMP provided a reliable way to coax certain cell types into maturing and extending processes. You see the direct changes in cell morphology, as well as differences in gene expression patterns when the cells experience cAMP analogs in their medium. Animal researchers measure how db-cAMP shifts signaling pathways, but they keep a clear separation between substances meant for live animal models or even human trials and those intended for the bench.
Most sources supplying db-cAMP for research do not perform testing compatible with clinical standards. Levels of endotoxins, heavy metals, or residual solvents can vary in ways that manufacturers do not usually disclose on datasheets. This is why recommendations always keep db-cAMP with a research-only label firmly in the research context. Trying to shortcut this separation only creates trouble, by undermining the safety cushion built into accredited research and clinical work.
The pressure to innovate can tempt some labs to blur the lines between research- and clinical-grade chemicals. In the fast pace of discovery, taking shortcuts threatens more than the current experiment. Results may hang on the presence of a trace contaminant that was not controlled or reported, and grant funders or journals look skeptically at data derived from substances used out of context. Responsible researchers draw this line clearly. Universities provide oversight, and funding agencies increasingly audit purchases to make sure chemicals are sourced and used as intended.
Keeping records updated and storing reagents in marked locations anchor these standards in everyday lab activity. Manufacturers can support this clarity with transparent datasheets listing lot-specific testing (such as heavy metal and endotoxin checks), even for research-grade substances. Teams can also set up cross-checks before ordering or mixing solutions for critical work. A culture of sharing experience—pinpointing when a research-grade chemical led to unexpected results—helps raise the whole lab’s standards.
In the end, research-only labels on db-cAMP and similar chemicals safeguard both the process and the people. They serve as reminders to use each substance with care and keep boundaries clear across all parts of the scientific journey.| Names | |
| Preferred IUPAC name | sodium (3R,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(butanoyloxy)oxolan-2-ylmethyl phosphate |
| Other names |
Dibuturyl cAMP sodium salt N6,2′-O-dibutyryladenosine 3′:5′-cyclic monophosphate sodium salt dbcAMP sodium salt DB-cAMP sodium salt Dibutyryl cyclic AMP sodium salt |
| Pronunciation | /daɪˈbjuːtɪrɪl ˈsaɪklɪk əˈdiːnəˌsiːn ˌmɒnəˈfɒsˌfeɪt ˈsoʊdiəm/ |
| Identifiers | |
| CAS Number | 37279-89-1 |
| Beilstein Reference | 1840991 |
| ChEBI | CHEBI:34745 |
| ChEMBL | CHEMBL358434 |
| ChemSpider | 20246 |
| DrugBank | DB03315 |
| ECHA InfoCard | 03e1aab7-d1b5-4518-87df-3bfa9e0d8ef1 |
| EC Number | 206-121-9 |
| Gmelin Reference | 100841 |
| KEGG | C00575 |
| MeSH | Dibutyryl Cyclic AMP |
| PubChem CID | 451388 |
| RTECS number | GH7000000 |
| UNII | Z688L3D5LQ |
| UN number | Not regulated |
| CompTox Dashboard (EPA) | DTXSID0046547 |
| Properties | |
| Chemical formula | C18H27N5Na2O8P |
| Molar mass | 492.43 g/mol |
| Appearance | White powder |
| Odor | Odorless |
| Density | 0.5-0.7 g/cm³ |
| Solubility in water | Soluble in water |
| log P | -2.2 |
| Acidity (pKa) | 13.0 |
| Basicity (pKb) | pKb ~5.85 |
| Refractive index (nD) | 1.520 |
| Viscosity | Viscous liquid |
| Dipole moment | 6.5 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 365.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | G04BE02 |
| Hazards | |
| Main hazards | Hazardous if swallowed, inhaled, or in contact with skin; causes eye, skin, and respiratory tract irritation. |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H315, H319, H335 |
| Precautionary statements | P280-P305+P351+P338-P337+P313 |
| NFPA 704 (fire diamond) | 1-1-0 |
| LD50 (median dose) | LD50 (median dose): >1 g/kg (rat, intravenous) |
| NIOSH | Not Listed |
| PEL (Permissible) | Not established |
| REL (Recommended) | REL (Recommended): 10 mg/mL |
| IDLH (Immediate danger) | Not listed |
| Related compounds | |
| Related compounds |
Cyclic adenosine monophosphate (cAMP) 8-Bromo-cAMP N6-Benzoyl-cAMP Sp-cAMPS Rp-cAMPS Dibutyryl-cGMP 8-pCPT-cAMP Adenosine monophosphate (AMP) Adenosine |
